Snapshot from Aug 24, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / Companies / Frazier Life Sciences
Entity

Frazier Life Sciences

Tracked across 2 events · 12 articles · First seen Jul 24, 2026 · Last active Aug 19, 2026

Sentiment
25
Attention
4
Events
2
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
Events (2)
4 50
Business
Fulcrum and Slate Medicines merger
Fulcrum Therapeutics and Slate Medicines have signed a definitive all-stock merger agreement to create a combined company focused on next-generation migraine treatments. The combined entity will operate as Slate Medicines and trade on Nasdaq under…
Impact: Frazier Life Sciences led the $245 million private placement financing supporting the merger, gaining a significant stake in the combined company.
Aug 17, 2026 · 6 articles
2 0
Business
MannKind $50M Private Placement
Impact: Frazier Life Sciences led the private placement as a key institutional investor, signaling confidence in MannKind's prospects.
Jul 24, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Frazier Life Sciences live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.